Nektar Therapeutics · NASDAQ:NKTR

FMR LLC reported a 11.10% stake in Nektar Therapeutics (Schedule 13G)

Event Feb 27, 2026 · Filed Mar 6, 2026

FMR LLC reported a 11.10% stake in Nektar Therapeutics, 3,036,761 shares, as a passive investor on Feb 27, 2026. Filed Mar 6, 2026 (Schedule 13G).

Stake
11.10%
Shares
3,036,761
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC11.10%3,036,761
Abigail P. Johnson11.10%3,036,761

Source

View original at SEC

Related